![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
20
Surya Pharmaceutical Ltd. Chandigarh In, based in India, is a pharmaceutical company.
One of their significant offerings is Cefaclor, supported by a 'Withdrawn by EDQM Failure to CEP procedure' Certificate of Suitability (CEP) with the number R0-CEP 2009-136 - Rev 00
This Chemical Type CEP, issued on August 21, 2012, remains in force until January 10, 2014, ensuring its reliability within the pharmaceutical industry.
Substance Number 986 associated with this CEP further emphasizes